Brent Rutland
Chief Tech/Sci/R&D Officer en KORU MEDICAL SYSTEMS, INC. .
Perfil
Brent Rutland is currently the Vice President-Medical Affairs at KORU Medical Systems, Inc. Prior to this, he worked as the Senior Director-Health Outcomes at La Jolla Pharmaceutical Co. from 2018 to 2022.
He also served as the Senior Medical Science Liaison at Baxter International, Inc. from 2016 to 2017.
Mr. Rutland completed his undergraduate degree at Texas A&M University and holds an MBA from the University of Houston.
He also obtained a graduate degree from the University of North Carolina at Chapel Hill.
Cargos activos de Brent Rutland
| Empresas | Cargo | Inicio |
|---|---|---|
| KORU MEDICAL SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Brent Rutland.
| Empresas | Cargo | Fin |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | 01/10/2022 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/07/2017 |
Formación de Brent Rutland.
| Texas A&M University | Undergraduate Degree |
| University of Houston | Masters Business Admin |
| University of North Carolina at Chapel Hill | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| KORU MEDICAL SYSTEMS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Brent Rutland
